Clinical Trial

MPR for Stroke Risk Assessment of ICAS

Recruiting
View on ClinicalTrials.gov →
Summary
Intracranial atherosclerotic stenosis (ICAS) carries substantial stroke risk despite optimal medical treatment. Current risk stratification relies primarily on stenosis severity, but novel hemodynamic markers may improve prediction. In this multiple prospective registry study we aim to investigate whether regional hemodynamics, measured by a novel Magnetic resonance imaging-derived Pressure Ratio (MPR) technique, are associated with stroke risk in ICAS.
Trial Details
NCT Number NCT07309718
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Xuanwu Hebei Hospital, Xuanwu Xiongan Hospital, Xuanwu Chifeng Hospital, Xuanwu Jinan Hospital
Conditions ICAS - Intracranial Atherosclerosis, Stroke Ischemic, Hemodynamic
Enrollment 400 participants
Start Date 2025-12-01
Primary Completion 2027-12-15 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-30